Iniciamos este libro con algunos conceptos básicos y elementales para una comprensión real e intuitiva de lo que es la Estadística Aplicada, sobre todo su aplicación a los problemas de la Enfermería y especialmente la especialidad de Matrona.

Iniciamos este libro con algunos conceptos básicos y elementales para una comprensión real e intuitiva de lo que es la Estadística Aplicada, sobre todo su aplicación a los problemas de la Enfermería y especialmente la especialidad de Matrona.

Ortega traces the course of Western civilization backward, searching out what makes a civilization rise or fall and offering a way of looking at our own time. Based on a series of lectures on A. J. Toynbee's A Study of History.

This book explains in a clear and simple way what life is and how it flows within our cells, between people and through people. It is a practical manual that will help us to "feel" life, to vibrate and breathe the life inside of our bodies and of all living beings. A key focus of this work is how emotional impact affects our pericardium, which is the membrane that envelops, maintains and protects the heart.

This title, first published in 1975, analyses the ways in which developments in Victorian universities have shaped both the structure and the assumptions of British higher education in the twentieth century. No period of British higher education has been more full of change nor so rooted in fundamental debate than the second half of the nineteenth century. Its lasting impact makes it crucial for an understanding both of this period of Victorian social history and of the contemporary system of higher education in Britain. This title will be of interest to students of history and education.

Geschiedenis van het onderwijs en de sociale achtergronden in Duitsland, Frankrijk en Groot-Brittannië in de 19e en 20e eeuw, op enkele punten vergeleken met het Amerikaanse onderwijs

In 1992, the Falk Symposium No. 70 dealt with the topic `Immunology and Liver'. At that time basic mechanisms of immunology as well as immunopathogenetic mechanisms in viral and autoimmune liver diseases were discussed. Now, 7 years later, the Falk Symposium No. 114, held in Basel, Switzerland, October 20-21 1999 (Part I of the Basel Liver Week 1999), focused on immunology in autoimmune liver diseases. In the first section basic mechanisms of autoimmunity are presented, including the relevance of superantigens and the role of apoptosis. A further topic is the latest developments concerning animal models for autoimmune diseases. Recently the International Autoimmune Hepatitis Group newly defined and reclassified the syndrome of autoimmune hepatitis. Autoimmune hepatitis is now identified and studied in all parts of the world, including Asia and South America. A special variant of autoimmune hepatitis was identified as one organ manifestation of the autoimmune polyendocrine syndrome type 1, a genetic disease caused by mutations in a single transcription factor. Drug- and hepatitis-virus induced immune mediated liver diseases may serve as models for nonhepatic immune mediated disorders. DNA technology has increased our knowledge of the immunogenetic background of autoimmune liver diseases. Among the cholestatic immune mediated liver diseases, significant progress has been made concerning primary biliary cirrhosis, in particular regarding the identification of mitochondrial antigens and the characterisation of the immune reactions directed at them. The involvement of infectious agents in PBC as well as the definition of overlap syndromes is a particular focus for basic and clinical research in this area. Concerning the therapy of autoimmune liver diseases, corticosteroids and azathioprin remain the state of the art for autoimmune hepatitis, while bile acids have become well established in treatment of primary biliary cirrhosis as well as primary sclerosing cholangitis. New drugs in the future will include topical steroids such as budesonide and new immunosuppressive agents like mofetil/mycophenolate. Liver transplantation is the treatment of choice for end stage liver diseases; all autoimmune liver diseases are among the best candidates for liver transplantation. Hopefully, new therapeutic strategies based on the results obtained from experimental models will become everyday clinical practice in the next decade. Therefore this symposium concludes with a discussion.